Long-term glycemic control relates to mortality in type II diabetes

Diabetes Care

Volumn 18, Issue 12, 1995, Pages 1534-1543

  Andersson, Dan K G ^a,b   Svärdsudd, Kurt ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Child Health Care Unit   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; HEART DISEASE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; SURVIVAL;

EID: 0028826119     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.18.12.1534     Document Type: Article

References (58)

1. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 59:8-13, 1979
2. Pyörälä K: Diabetes and coronary heart disease. Acta Endocrinol 110 (Suppl. 272): 11-19, 1985
3. Lapidus L, Bengtsson C, Blohmé G, Lindquist O, Nyström E: Blood glucose, glucose tolerance, and manifest diabetes in relation to cardiovascular disease and death in women. Acta Med Scand 218: 455-462, 1985
4. Ohlson L-O, Bjurö T, Larsson B, Eriksson H, Svärdsudd K, Welin L, Wilhelmsen L: A cross-sectional analysis of glucose tolerance and cardiovascular disease in 67-year-old men. Diabetic Med 6:112-120, 1989
5. Panzram G, Zabel-Langhennig R: Prognosis of diabetes mellitus in a geographically defined population. Diabetologia 20:587-591, 1981
6. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727), p. 29-31
7. Garcia MJ, McNamara PM, Gordon T, Kannel WB: Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 23: 105-111, 1974
8. Wingard DL, Barrett-Connor E, Criqui MH, Suarez L: Clustering of heart disease risk factors in diabetic compared to nondiabetic adults. Am J Epidemiol 117:19-26, 1983
9. Jarrett RJ, Shipley MJ: Mortality and associated risk factors in diabetics. Acta Endocrinol 110 (Suppl. 272):21-26, 1985
10. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
11. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Mortality from coronary heart disease and stroke in relation to degree of glycemia: the Whitehall Study. BMJ 287: 867-870, 1983
12. Laakso M, Pyörälä K, Voutilainen E, Marniemi J: Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects. Am J Epidemiol 125:611-621, 1987
13. Stout R: Insulin and atheroma: 20-yr perspective. Diabetes Care 13:631-654, 1990
14. Fontbonne AM, Eschwège EM: Insulin and cardiovascular disease: Paris Prospective Study. Diabetes Care 14:461-469, 1991
15. Welin L, Eriksson H, Larsson B, Ohlson L-O, Svärdsudd K, Tibblin G: Hyperinsulinaemia is not a major coronary risk factor in elderly men: the Study of Men Born in 1913. Diabetologia 35:766-770, 1992
16. Uusitupa M, Pyörälä K, Laakso M: Metabolic control and macrovascular disease. In International Textbook of Diabetes Mellitus. Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, Eds. Oxford, U.K., Wiley, 1992, p. 1471-1485
17. West KM, Ahuja MMS, Bennett PH, Czyzyk A, De Acousta OM, Fuller JH, Grab B, Grabauskas V, Jarrett RJ, Kosaka K: The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study. Diabetes Care 6:361-369, 1983
18. Donahue RP, Orchard TJ: Diabetes mellitus and macrovascular complications. Diabetes Care 15:1141-1155, 1992
19. Jarrett RJ: Is insulin atherogenic? Diabetologia 31:71-75, 1988
20. Jarrett RJ: In defense of insulin: a critique of syndrome X. Lancet 340:469-471, 1992
21. Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvist U: Intensified conventional insulin treatment retards the microvascular complications in insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med 230:101-108, 1991
22. Reichard P, Nilsson BY, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
23. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:683-689, 1993
24. Klein R: Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18:258-268, 1995
25. Gries FA, Alberti KGMM: Management of non-insulin-dependent diabetes mellitus in Europe: a consensus statement. Diabetic Med 5:275-281, 1988
26. Andersson DKG, Svärdsudd K, Tibblin G: Prevalence and incidence of diabetes in a Swedish community 1972-1987. Diabetic Med 8:428-434, 1991
27. Andersson DKG, Lundblad E, Svärdsudd K: A model for early diagnosis of type 2 diabetes mellitus in primary health care. Diabetic Med 10:167-173, 1993
28. Klassifikation av sjukdomar 1968: systematisk förteckning: tredje upplagan. Stockholm, Socialstyrelsen, 1973
29. Klassifikation av sjukdomar 1987: systematisk förteckning. Stockholm, Socialstyrelsen, 1986
30. Bradley JV: Distribution-Free Statistical Tests. London, Prentice-Hall, 1968, p. 68-86
31. Cox DR: Regression models and life-tables. J Roy Statist Soc 34:187-220, 1972
32. Wettre S, Arnqvist HJ, von Schenck H: Assessment of glycaemic control in non-insulin-dependent diabetes mellitus. Scand J Clin Lab Invest 53:163-170, 1993
33. Derfler K, Waldhäusl W, Zyman HJ, Howorka K, Holler C, Freyler H: Diabetes care in rural area: clinical and metabolic evaluation. Diabetes Care 9:509-517, 1986
34. Stâlhammar J, Bergman U, Boman K, Dahlén M: Metabolic control in diabetic subjects in three Swedish areas with high, medium, and low sales of antidiabetic drugs. Diabetes Care 14:12-19, 1991
35. Uusitupa M, Siitonen O, Pyörälä K, Aro A, Penttila I, Voutilainen E: The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed type 2 (non-insulin-dependent) diabetes. Diabetologia 28:653-659, 1985
36. Gall M-A, Rossing P, Skøtt P, Damsbo P, Vaag A, Bech K, Dejgaard A, Lauritzen M, Lauritzen E, Hougaard P, Beck-Nielsen H, Parving HH: Prevalence of micro- and macroalbuminuria, arterial hypertension and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34:655-661, 1991
37. Horan MJ: Diabetes and hypertension. In Diabetes in America. Harris MI, Hamman RF, Eds. Washington, DC, U.S. Dept. of Health and Human Services, 1985, (NIH publ. no. 85-1468)
38. Haffner SM, Mitchell BD, Pugh JA, Stern MP, Kozlowski MK, Hazuda HP, Patterson JK, Klein R: Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care 12:530-536, 1989
39. Diabetes Drafting Group: Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres: the World Health Organization Multinational Study of vascular disease in diabetics. Diabetologia 28:615-640, 1985
40. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K: 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level and abnormalities in lipoprotein composition in non-insulin dependent diabetic and non-diabetic subjects. Circulation 82:27-36, 1990
41. Ishihara M, Tukimura Y, Yamada T, Ohto K, Yoshizama K: Diabetic complications and their relationships to risk factors in a Japanese population. Diabetes Care 7:533-538, 1984
42. Kuebler TW, Bendick PJ, Fineberg SE, Markand ON, Norton JA Jr, Vivicor FN, Clark CMJ: Diabetes mellitus and cerebrovascular disease: prevalence of carotic artery occlusive disease and associated risk factors in 482 adult diabetic patients. Diabetes Care 6:274-278, 1983
43. Laakso M: Atherosclerotic Vascular Disease and Its Risk Factors in Non-Insulin Dependent Diabetics in East Finland: Original Re-ports 5. Kuopio, Finland, University of Kuopio, 1986
44. Sprafka JM, Pankow J, McGovern PG, French LM: Mortality among type II diabetic individuals and associated risk factors: The Three City Study. Diabetic Med 10:627-632, 1993
45. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K: Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175-1184, 1993
46. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960-967, 1994
47. Malmberg K: Myocardial infarction and Diabetes Mellitus. PhD thesis. Stockholm, ReproPrint AB, 1994
48. Ostrander LD, Francis T, Hayner NS, Kjelsberg MO, Epstein FH: The relationship of cardiovascular disease to hyperglycaemia. Ann Intern Med 62:1188-1198, 1965
49. Jarrett RJ, McCartney P, Keen H: The Bedford Study: ten-year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 22:79-84, 1982
50. Eschwège E, Ducimetière P, Thibult N, Richard JL, Claude JR, Rosselin GE: Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: the Paris Prospective Study, ten years later. Horm Metah Res 15 (Suppl.):41-45, 1985
51. Pyörälä K, Savolainen E, Kaukola S, Haapakoski J: Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9.5-year follow-up of the Helsinki Policemen Study population. Acta Med Scand 701 (Suppl. 701):38-52, 1985
52. Pan W-H, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, Stamler R, Smith D, Collette P, Stamler J: Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 123:504-516, 1986
53. Stout RW: Glucose inhibits replication of cultured human endothelial cells. Diabetologia 23:436-439, 1982
54. Turner JL, Bierman EL: Effects of glucose and sorbitol on proliferation of cultured human fibroblasts and arterial smooth muscle cells. Diabetes 27:583-588, 1978
55. Cerami A, Vlassara H, Brownlee M: Role of advanced glycosylation products in complications of diabetes. Diabetes Care 11 (Suppl. 1):73-79, 1988
56. Colwell JA, Lopes-Virella MF: A review of the development of large-vessel disease in diabetes mellitus. Am J Med 85 (Suppl. 5A):113-118, 1988
57. Beisswenger PJ, Moore LL, Curphey TJ: Relationship between glycemic control and collagen-linked advanced glycosylation end products in type 1 diabetes. Diabetes Care 16:689-694, 1993
58. U.K. Prospective Diabetes Study Group: UKPDS VIII: study design, progress and performance. Diabetologia 34:877-890, 1991